TalbottJA. Presidential Address: Our patients' future in a changing world: The imperative for psychiatric involvement in public policy. Am J Psychiatry1985; 142: 1003–8
2.
ParkerGO'DonnellMWalterS. Changes in the diagnosis of the functional psychoses associated with the introduction of lithium. Br J Psychiatry1985; 146: 377–82
3.
BalintMHuntJJoyceDMarinkerMWoodcockJ. Treatment or diagnosis. 2nd ed.London: Tavistock, 1984
4.
WaltonJ. The science of clinical neurology. J R Soc Med1986; 79: 5–14
5.
CarrollBJFeinbergMGredenJF, A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility. Arch Gen Psychiatry1981; 38: 15–22
6.
AranaGWBaldessarinRJOrnsteenM. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiatry1985; 42: 1193–204
7.
LaboritHHuguenardPAlluaumeR. Un nouveau stabilisateur végétatif (le 4560 RP). Press Méd1952; 60: 206–8
8.
BowdenCL. Current treatment of depression. Hosp Community Psychiatry1985; 36: 1192–200
9.
DupontWD. Randomized vs. historical clinical trials: Are the benefits worth the cost?Am J Epidemiol1985; 122: 940–6
CoccaroEFSieverLJ. Second generation antidepressants: A comparative review. J Clin Pharmacol1985; 25: 241–60
12.
MøllerSEReisbyNElleyJKrautwaldOOrtmannJLarsenOB. Biochemical and diagnostic classification and serum drug levels: Relation to antidepressive effect of imipramine. Neuropsychobiology1985; 13: 160–6
13.
MøllerSE. Tryptophan to competing amino acids ratio in depressive disorder: Relation to efficacy of antidepressive treatments. Acta Psychiatr Scand1985; 72 (Suppl 325): 1–31
14.
MorganRGopalaswamyAK. Prescribing of psychotropic drugs. Br J Psychiatry1985; 147: 454
15.
PichotP. Nosological developments in European psychiatry and psychopharmacology. Pharmacopsychiatry1986; 19: 23–5
16.
KielholzPTerzaniSGastparM. Treatment for therapy resistant depressions. Int Pharmacopsychiatry1979; 14: 94–100
17.
PöldingerW. Die biologisch-pharmakologisch orientierten Behandlungsmethoden der Depressionen unter besonderer Berücksichtigung der Anliegen der Praxis. Wien Klin Wochenschr1985; 97: 165–75
18.
BechPHippiusH eds. Joining together clinical assessment systems for depression. Acta Psychiatr Scand1983;68 (Suppl 310): 1–130
19.
BechPKastrupMRafaelsenOJ. Mini-compendium of rating scales for states of anxiety depression mania with corresponding DSM-III syndromes. Acta Psychiatr Scand1986; 73 (Suppl 326): 1–37
20.
CleghornJM. Formulation: A pedagogic antidote to DSM-III. Compr Psychiatry1985; 26: 504–12
21.
VaillantGE. The disadvantages of DSM-III outweigh its advantages. Am J Psychiatry1984; 141: 542–5
22.
WilliamsJBW. The multiaxial system of DSM-III: Where did it come from and where should it go? 1. Its origins and critiques. Arch Gen Psychiatry1985; 42: 175–36
23.
FeinsteinAR. A critical overview of diagnosis in psychiatry. In: RakoffVMStancerHCKedwardHB, eds. Psychiatric diagnosis. New York: Brunner/Mazel, 1977: 189–206
24.
MorozovPV. Transcultural aspects of classification of mental disorders. Pharmacopsychiatry1986; 19: 26–8
25.
KendellRE. Reflections on psychiatric classification — for the architects of DSM-IV and ICD-10. Integrative Psychiatry1984; 2: 43–57
